Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- By-Mycin 100mg Capsule – PA1457/010/002
- Genotropin 5.3mg Powder and Solvent for Solution for Injection – PA0822/128/001
- Hypocase 0.5mg Tablet – PA0822/195/001
- Isoptin 40mg Film Coated Tablet – PA2010/003/001
- Isoptin 80mg Film Coated Tablet – PA2010/003/002
- Lercandipine 10mg Tablet – PA0126/187/001
- Lercandipine 20mg Tablet – PA0126/187/002
- Lipantil Micro 67mg Capsule – PA2010/015/001
- Oxaliplatin 5mg/ml Concentrate for Solution for Infusion – PA2059/049/001
- Sofradex Ear/Eye Drops – PA0540/070/002
- Teveten 600mg Film Coated Tablet – PA2010/017/002
The following shortage has been resolved and supply has resumed to the Irish market:
- Alprazolam 0.2mg Tablet – PA0711/140/001
- Campral EC 333mg Gastro-Resistant Tablet – PA2286/007/001
- Champix 1mg Film Coated Tablet – EU/1/06/360/016
- Cozatan Comp 50mg/12.5mg Film Coated Tablet – PA0126/184/001
- Estradot 100mcg/day Transdermal Patch – PA0896/010/004
- Instanyl 100mcg Nasal Spray – EU/1/09/531/014-017
- NeoMercazole 5mg Tablet – PA1142/002/001
- Selectol 200mg Tablet – PA0540/126/001
- Sublimaze 50mcg/ml Solution for Injection – PA0748/044/001
- Tamox 20mg Tablet – PA0711/022/002
- Triapin 2.5mg/2.5mg Prolonged Release Tablet – PA0540/082/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.